# CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction

> **NCT00893360** · PHASE1 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 31 (actual)

## Conditions studied

- Recent Myocardial Infarction
- Ventricular Dysfunction

## Interventions

- **BIOLOGICAL:** Autologous stem cell infusion
- **BIOLOGICAL:** Autologous stem cell infusion

## Key facts

- **NCT ID:** NCT00893360
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-08
- **Final completion:** 2012-02
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2014-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00893360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00893360, "CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00893360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*